Technicians working in an mRNA bioprocessing lab with stainless steel bioreactors.

PARTNERSHIPS

18 Nov 2025

New Alliance Aims to Steady the mRNA Supply Chain

Wacker Biotech and RNAV8 Bio join forces to streamline mRNA development and create a more predictable path to the clinic

mRNA strand connecting to virus and syringe representing genetic therapy

INNOVATION

14 Nov 2025

Can mRNA Rewrite the Future of Rare Disease Care?

US labs and biotech firms push mRNA deeper into rare disease therapy, stirring hope and investment

3D illustration of an mRNA strand, syringe, and virus particle symbolizing mRNA research.

INSIGHTS

10 Nov 2025

What BioNTech’s CureVac Deal Says About mRNA’s Future

BioNTech’s $1.25B CureVac deal pushes mRNA beyond vaccines toward cancer treatment

AbbVie corporate building exterior symbolizing major expansion into in-vivo mRNA therapies

PARTNERSHIPS

20 Aug 2025

Inside AbbVie's High-Stakes Deal on Next-Gen mRNA Therapy

AbbVie's Capstan buy signals a bold leap into in-vivo mRNA therapies, reshaping the race for next-gen autoimmune treatments.

Scientist analyzing samples with digital DNA displays representing mRNA cancer research

RESEARCH

14 Aug 2025

Early Cancer Trial Puts mRNA in the Spotlight

Strand's STX-001 shows early tumor-fighting promise as mRNA shifts from vaccines to therapeutics.

Modern biotech office with illuminated DNA sculpture symbolizing advances in mRNA cancer innovation

INVESTMENT

9 Aug 2025

mRNA's Next Act: Strand Secures $153M for Cancer Fight

Boston biotech secures major funding as investors back oncology applications of mRNA

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.